Diphtheria drug shortages put thousands of children at risk in Northern Nigeria – Businessday NG

Thousands of children in northern Nigeria face increased risks of severe illness and death from diphtheria as shortages of the life-saving drugs used to treat the disease in addition to low vaccination coverage continue to fuel infections.

The global shortage of diphtheria antitoxin (DAT), the only specific treatment that neutralises the toxin produced by the disease, is undermining efforts to control Nigeria’s outbreak, with medical teams increasingly struggling to secure enough supplies to treat infected children, Médecins Sans Frontières (MSF) has warned.

“The global shortage of diphtheria antitoxin is becoming a matter of life and death. Our stocks are dangerously low, and we risk being unable to treat children and save lives as the outbreak continues,” David Kizito, MSF’s medical coordinator in Nigeria said.

DAT is most effective when administered within 48 hours of the onset of symptoms. However, MSF said its medical teams repeatedly face situations where supplies are insufficient or unavailable, forcing them to ration treatment and potentially compromising patients’ chances of survival.

The international medical humanitarian organisation called on the Federal Government, state authorities, donors and international partners to urgently secure available supplies of the drug and vaccines and ensure their timely clearance at ports of entry and distribution to affected communities.

Although the antitoxin is included in the World Health Organisation’s Model List of Essential Medicines, global availability remains inconsistent, partly because manufacturers produce limited quantities due to unpredictable demand and low financial returns.

Nigeria has battled a major diphtheria outbreak since late 2022, with more than 41,000 suspected cases, over 24,000 confirmed infections and more than 1,260 deaths recorded nationwide since the outbreak began.

Northern states, including Bauchi, Borno, Kaduna, Katsina, Kano, Plateau, Sokoto and Zamfara, remain particularly affected, with several experiencing recent increases in infections.

In 2026 alone, Nigeria recorded 12,977 suspected cases, 10,476 confirmed infections and 406 deaths as of August 9, according to figures provided by MSF.

The organisation said low immunisation coverage, particularly in rural communities, was contributing to continued transmission, leaving many children vulnerable to a disease that can largely be prevented through routine vaccination.

The scale of the vaccination gap is evident in Zamfara State, where only 25,000 of the 90,000 vaccine doses required for a reactive vaccination campaign had been supplied, leaving approximately three out of every four children unreached.
Following Zamfara’s declaration of an outbreak in September, MSF-supported facilities in Gusau recorded more than 671 admissions in one month from October 6. Most of the patients were children, while four out of every five admitted patients had not been vaccinated.

MSF said it was working with government health authorities to secure additional vaccine supplies and implement a large-scale vaccination campaign in the state.

The organisation has also supported vaccination activities in other affected states. In Kano, it partnered with the state Ministry of Health to conduct two rounds of vaccination in April and June, administering more than 835,000 vaccine doses to children.

In Sokoto, two vaccination rounds conducted between February and April reached 49,018 children under the age of 15.

Since the beginning of its response this year, MSF said it had treated more than 9,000 diphtheria patients through facility-based and community-based care, while supporting surveillance, infection prevention and control, community engagement, referrals and health promotion.

The outbreak has also placed a heavy burden on families, particularly those with limited knowledge of the disease and difficulties accessing timely healthcare.

Shafa’atu, a mother whose three children were treated for diphtheria at an MSF-supported hospital in Sokoto, said her family was initially unaware of the dangers of the infection.
“We were very worried when our first child became sick because we knew very little about diphtheria at the time,” she said.
“My child struggled to eat, and whenever he ate, he vomited. Diphtheria is a dangerous disease.”

Diphtheria is a life-threatening bacterial infection transmitted mainly through respiratory droplets and contact with infected wounds. It can cause sore throat, fever, swollen lymph nodes and the formation of a thick membrane in the throat that can obstruct breathing.

In severe cases, the toxin produced by the bacteria can damage the heart, nerves and kidneys. Without appropriate treatment, between 30 and 40 percent of people with diphtheria may die.

MSF said sustained investment in routine immunisation was necessary to build community immunity and prevent future outbreaks, while manufacturers and global health partners must expand production of the antitoxin to address critical treatment needs in Nigeria and other countries experiencing rising infections.

The organisation warned that without reliable supplies of the drug, vaccines and other essential medicines, medical teams would continue to face difficulties treating patients and containing transmission.

Related News

Advertisement

Source:

Businessday NG